CRBP SCHEDULE 13G: SEC filing
Filed with the SEC on · accession 0001346824-26-000243
CRBP filed a SCHEDULE 13G (schedule 13g) with the SEC on Sep 30, 2026. RA Capital Management, Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund filed a joint filing agreement as an exhibit to a Schedule 13G regarding their beneficial ownership of Corbus Pharmaceuticals common stock. The stock moved +2.9% by the first close after the filing.
Summary of the filing
RA Capital Management, Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund filed a joint filing agreement as an exhibit to a Schedule 13G regarding their beneficial ownership of Corbus Pharmaceuticals common stock. The agreement allows the filers to submit a single combined Schedule 13G/13D on behalf of all parties.
Key details
How CRBP stock reacted
Close before
$6.63
Sep 29, 2026
First close after
+2.87%
$6.82
5 trading days
-12.82%
$5.78
Since filing
-53.70%
$3.07
✦ Ask GOAX AI about this filing — what it means for CRBP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CRBP?
Click hereFrequently asked questions
What did CRBP file with the SEC on Sep 30, 2026?
CRBP filed a SCHEDULE 13G (SEC filing). RA Capital Management, Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund filed a joint filing agreement as an exhibit to a Schedule 13G regarding their beneficial ownership of Corbus Pharmaceuticals common stock. The agreement allows the filers to submit a single combined Schedule 13G/13D on behalf of all parties.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did CRBP stock react to this filing?
CRBP closed at $6.63 before the filing and $6.82 on Sep 30, 2026 (+2.87%). Five trading days later: $5.78 (-12.82%).
Other CRBP SEC filings
- SCHEDULE 13G/A · SEC filingNov 2, 2026
- SCHEDULE 13G/A · SEC filingOct 29, 2026
- 8-K · SEC filingOct 15, 2026
- 8-K · Fda approvalSep 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 424B5 · Secondary offeringAug 7, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · Executive departureJul 6, 2026
- 8-K · SEC filingMay 26, 2026
Get alerts when CRBP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days